Use of a novel sonosensitizer in sonodynamic therapy of U251 glioma cells in vitro

Experimental and Therapeutic Medicine

Volumn 3, Issue 2, 2012, Pages 273-278

  Chen, Zhiqiang ^a   Li, Jianhua ^a   Song, Xueming ^a   Wang, Zhi ^a   Yue, Wu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Human U251 glioma cells; Reactive oxygen species; Sonodynamic therapy; ZnPcS 2P 2

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOMA; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; PROTEIN EXPRESSION; SONODYNAMIC THERAPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND THERAPY; WESTERN BLOTTING;

EID: 84855389357     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.390     Document Type: Article

References (26)

1. Perilongo G: Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma. J Neurooncol 75: 301-307, 2005.
2. Yumita N, Nishigaki R, Umemura K and Umemura S: Hematoporphyrin as a sensitizer of cell damaging effect of ultrasound. Jpn J Cancer Res 80: 219-222, 1989.
3. Kessel D, Lo J, Jeffers R, Fowlkes JB and Cain C: Modes of photodynamic vs. sonodynamic cytotoxicity. J Photochem Photobiol B 28: 219-221, 1995.
4. Huang JL, Chen NS, Huang JD, et al: Metal phthalocyanine as photosensitizer for photodynamic therapy(PDT) - preparation, characterization and anticancer activities of an amphiphilic phthalocyanine ZnPcS2P2. Sci China Ser B 44: 113-122, 2001.
5. Liu W, Chen N, Jin H, et al: Intravenous repeated-dose toxicity study of ZnPcS2P2-based-photodynamic therapy in beagle dogs.Regul Toxicol Pharmaco 147: 221-231, 2007.
6. Huang HF, Chen YZ, Wu Y and Chen P: Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy. Bone Marrow Transplant 37: 213-217, 2006.
7. Huang HF, Chen YZ and Wu Y: Experimental studies of the effects of ZnPcS2P2-based-photodynamic therapy on bone marrow purging. Chin Med J (Engl) 118: 105-110, 2005.
8. Huang HF, Chen YZ and Wu Y: Mitochondria-dependent apoptosis induced by a novel amphipathic photochemotherapeutic agent ZnPcS2P2 in HL60 cells. Acta Pharmacol Sin 26: 1138-1144, 2005.
9. Chowdhury I, Tharakan B and Bhat GK: Current concepts in apoptosis: the physiological suicide program revisited. Cell Mol Biol Lett 11: 506-525, 2006.
10. Dunn F, Averbuch AJ and O'Brien WD Jr: A primary method for the determination of ultrasonic intensity with the elastic sphere radiometer. Acoustica 38: 58-61, 1977.
11. Orie NN, Zidek W and Tepel M: Chemoattractant- and mitogen-induced generation of reactive oxygen species in human lymphocytes: the role of calcium. Exp Physiol 84: 515-520, 1999.
12. Kuroki M, Hachimine K, Abe H, et al: Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res 27: 3673-3677, 2007.
13. Li JH, Song DY, Xu YG, Huang Z and Yue W: In vitro study of haematoporphyrin monomethyl ether-mediated sonodynamic effects on C6 glioma cells. Neurol Sci 29: 229-235, 2008.
14. Barati AH and Mokhtari-Dizaji M: Ultrasound dose fractionation in sonodynamic therapy. Ultrasound Med Biol 36: 880-887, 2010.
15. Wang XB, Liu QH, Wang P, Zhang K, Tang W and Wang BL: Enhancement of apoptosis by sonodynamic therapy with protoporphyrin IX in isolate sarcoma 180 cells. Cancer Biother Radiopharm 23: 238-246, 2008.
16. Barnhart BC, Alappat EC and Peter ME: The CD95 type I/type II model. Semin Immunol 15: 185-193, 2003.
17. Aziz MH, Sundling KE, Dreckschmidt NE and Verma AK: Protein kinase C epsilon inhibits UVR-induced expression of FADD, an adaptor protein, linked to both Fas- and TNFR1-mediated apoptosis. J Invest Dermatol 129: 2011-2021, 2009.
18. Kim SG, Jong HS, Kim TY, et al: Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells. Mol Biol Cell 15: 420-434, 2004.
19. Choi SA, Kim SJ and Chung KC: Huntingtin-interacting protein 1-mediated neuronal cell death occurs through intrinsic apoptotic pathways and mitochondrial alterations. FEBS Lett 580: 5275-5282, 2006.
20. Felderhoff-Mueser U, Sifringer M, Pesditschek S, et al: Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol Dis 11: 231-245, 2002.
21. Milner AE, Palmer DH, Hodgkin EA, et al: Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells. Cell Death Differ 9: 287-300, 2002.
22. Liu Q, Wang X, Wang P, Qi H, Zhang K and Xiao L: Sonodynamic effects of protoporphyrin IX disodium salt on isolated sarcoma 180 cells.Ultrasonics 45: 56-60, 2006.
23. Quan-hong L, Shi-hui S, Ya-ping X, et al: Synergistic anti-tumor effect of ultrasound and hematoporphyrin on sarcoma 180 cells with special reference to the changes of morphology and cytochrome oxidase activity of tumor cells. J Exp Clin Cancer Res 23: 333-341, 2004.
24. Dai S, Hu S and Wu C: Apoptotic effect of sonodynamic therapy mediated by hematoporphyrin monomethyl ether on C6 glioma cells in vitro. Acta Neurochir 151: 1655-1661, 2009.
25. Reinecke F, Levanets O, Olivier Y, et al: Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells. Biochemistry 395: 405-415, 2006.
26. 2+ and the activation of caspase-3. Anticancer Res 26: 4379-4389, 2006.